Ziprasidone and hypokalemia: A case of 2 predisposing factors for QTc prolongation without development of torsades de pointes

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 7, Issue 3, 2005, Pages 134-136

  Simpson, B Rush ^a   Albanese Jr , Robert P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CLONAZEPAM; DOCUSATE SODIUM; NAPROXEN; OLANZAPINE; PROPRANOLOL; RANITIDINE; ZIPRASIDONE; ZOLPIDEM;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; HUMAN; HYPOKALEMIA; LABORATORY TEST; LETTER; MALE; PARANOID SCHIZOPHRENIA; PHYSICAL EXAMINATION; QT PROLONGATION; RHABDOMYOLYSIS; TORSADE DES POINTES;

EID: 28944437163     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/pcc.v07n0312     Document Type: Letter

References (17)

1. Kelly HG, Fay JE, Lavery SG. Thioridazine hydrochloride (Mellaril): its effects on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Can Med Assoc J 1963;89:546-554
2. Dessertenne F. Ventricular tachycardia with two variable opposing foci [in French]. Arch Mal Coeur Vaiss 1966;59:263-272
3. Fowler NO, McCall D, Chou TC, et al. Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol 1976;37:223-230
4. Roden DM. A practical approach to torsade de pointes. Clin Cardiol 1997;20:285-290
5. Mellaril (thioridazine). Physicians' Desk Reference. 54th ed. Montvale, NJ: Medical Economics; 2000:1108-1110
6. Glassman AH, Bigger JT. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001;158:1774-1782
7. DuBuske LM. Second-generation antihistamines: the risk of ventricular arrhythmias. Clin Ther 1999;21:281-295
8. Witchel HJ, Hancox JC. Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current. Clin Exp Pharmacol Physiol 2000;27:753-766
9. Scheidt S. Basic Electrocardiography. 2nd ed. West Caldwell, NJ: CIBA-GEIGY Pharmaceuticals Publishing: 1993:14-15
10. Haddad PM, Aderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002;62:1649-1671
11. Barnett AA. Safety concerns over antipsychotic drug, sertindole. Lancet 1996;348:256-257
12. Sertindole NDA 20-644. Rockville, Md: Food and Drug Administration, Psychopharmacological Drugs Advisory Committee: 1996
13. FDA Briefing Document for Zeldex Capsules (Ziprasidone). New York, NY: Pfizer Inc; 2000:116
14. Curry P, Fitchett D, Stubbs W, et al. Ventricular arrhythmias and hypokalemia. Lancet 1976;2:231-233
15. Berthet M, Denjoy I, Donger C, et al. C-terminal HERG mutations: the role of hypokalemia and KCNQ1-associated mutation in cardiac event occurrence. Circulation 1999;99:1464-1470
16. Yang T, Roden DM. Extracellular potassium modulation of drug block of I Kr: implications for torsade de pointes and reverse use dependence. Circulation 1996;93:407-411
17. Ziprasidone. Mosby's Drug Consult. St Louis, Mo: Mosby Publishing me; 2003:3309-3315